Evidence map›Paper›PMID 26464433›Full record

ArticleNucleic acids research2016

DTIE, a novel core promoter element that directs start site selection in TATA-less genes.

Nadav Marbach-Bar, Anat Bahat, Shaked Ashkenazi, Michal Golan-Mashiach, Ora Haimov, Shwu-Yuan Wu, Cheng-Ming Chiang, Anna Puzio-Kuter, Kim M Hirshfield, Arnold J Levine and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Core promoterome of barley embryo.Computational and structural biotechnology journal · 2024
    Article
  2. Genomic Space ofInternational journal of molecular sciences · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nadav Marbach-BarDept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
Anat BahatDept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
Shaked AshkenaziDept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
Michal Golan-MashiachDept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
Ora HaimovDept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel.
Shwu-Yuan WuSimmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Cheng-Ming ChiangSimmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Anna Puzio-KuterCancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA.
Kim M HirshfieldCancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA.
Arnold J LevineCancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA.
Rivka DiksteinDept. of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel rivka.dikstein@weizmann.ac.il.

Funding

E2-Cellular Complexes in HPV Chromatin TranscriptionR01CA103867 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHIANG, CHENG-MING · 2004 to 2017
$4.0M
NCI NIH HHS CA103867NCI NIH HHS R01 CA103867
6 · The paper itself

Abstract

The transcription start site (TSS) determines the length and composition of the 5' UTR and therefore can have a profound effect on translation. Yet, little is known about the mechanism underlying start site selection, particularly from promoters lacking conventional core elements such as TATA-box and Initiator. Here we report a novel mechanism of start site selection in the TATA- and Initiator-less promoter of miR-22, through a strictly localized downstream element termed DTIE and an upstream distal element. Changing the distance between them reduced promoter strength, altered TSS selection and diminished Pol II recruitment. Biochemical assays suggest that DTIE does not serve as a docking site for TFIID, the major core promoter-binding factor. TFIID is recruited to the promoter through DTIE but is dispensable for TSS selection. We determined DTIE consensus and found it to be remarkably prevalent, present at the same TSS downstream location in ≈20.8% of human promoters, the vast majority of which are TATA-less. Analysis of DTIE in the tumor suppressor p53 confirmed a similar function. Our findings reveal a novel mechanism of transcription initiation from TATA-less promoters.

Indexed as

Promoter Regions, GeneticAnimalsBase SequenceHEK293 CellsHumansMicroRNAsSequence Homology, Nucleic AcidTATA BoxTranscription, GeneticMicroRNAsMIRN22 microRNA, human

Identifiers

PMID26464433
PMCPMC4756809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.